|
Oct 8
|
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
|
|
Jun 24
|
CureVac Announces Voting Results of General Meeting
|
|
Apr 27
|
CureVac Full Year 2023 Earnings: Misses Expectations
|
|
Apr 25
|
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
|
|
Apr 24
|
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
|
|
Apr 24
|
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
|
|
Apr 24
|
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
|
|
Apr 24
|
CureVac to cut costs in restructuring
|
|
Dec 30
|
13 Best Get Rich Quick Stocks To Buy
|
|
Dec 22
|
These Analysts Just Made A Huge Downgrade To Their CureVac N.V. (NASDAQ:CVAC) EPS Forecasts
|
|
Dec 19
|
Rebel's Edge - December 19: $RUN, $AFRM, $CVAC, and College Football Recruits
|
|
Dec 19
|
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
|
|
Dec 19
|
CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
|
|
Dec 19
|
UPDATE 2-German court quashes CureVac patent after challenge by BioNTech
|
|
Sep 29
|
Why CureVac Stock Plunged Today
|
|
Sep 28
|
CureVac Reports Progress in Intellectual Property Infringement Case Against BioNTech in Germany
|
|
Sep 28
|
CORRECTED-German court suspends mRNA patent trial against BioNTech
|
|
Aug 8
|
Further weakness as CureVac (NASDAQ:CVAC) drops 9.7% this week, taking one-year losses to 40%
|